社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
微创脑科学(02172)
13.660
-0.360
-2.57%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
Sumire_9572
·
06-18 13:48
$微创脑科学(02172)$
开始直线拉升了，，，
$微创脑科学(02172)$ 开始直线拉升了，，，
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Sumire_9572
·
06-18 13:12
$微创脑科学(02172)$
马上拉升翻红，，，
$微创脑科学(02172)$ 马上拉升翻红，，，
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Sumire_9572
·
06-18 13:11
$微创脑科学(02172)$
本月有机会突破20+
$微创脑科学(02172)$ 本月有机会突破20+
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Sumire_9572
·
06-18 13:09
$微创脑科学(02172)$
感觉今天会翻红，，，近期牛股
$微创脑科学(02172)$ 感觉今天会翻红，，，近期牛股
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Sumire_9572
·
06-18 13:09
$微创脑科学(02172)$
继续低吸！！！
$微创脑科学(02172)$ 继续低吸！！！
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Sumire_9572
·
06-18 11:10
$微创脑科学(02172)$
开始直线拉升了！
$微创脑科学(02172)$ 开始直线拉升了！
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Sumire_9572
·
06-18 10:46
$微创脑科学(02172)$
低吸为主！！！16+
$微创脑科学(02172)$ 低吸为主！！！16+
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Sumire_9572
·
06-18 09:44
$微创脑科学(02172)$
低吸时刻！！！
$微创脑科学(02172)$ 低吸时刻！！！
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
港股解码
·
06-17 15:10
脑再生狂飙背后的玄机
6月16日最让人瞠目结舌的股价表现，当属纳斯达克上市的
$脑再生科技(RGC)$
。这家公司股价当天像坐火箭似的一路狂飙，接连触发多次熔断，最后收在60美元，涨幅高达283.12%。更夸张的是，从今年年初的0.13美元算起，这股价已经飙涨了460倍！ 受此带动，6月17日上午A股和港股脑机接口概念飙升，
$南京熊猫电子股份(00553)$
一度涨超56%，
$微创脑科学(02172)$
一度大涨45%，A股相关概念股南京熊猫（600775.SH）、麒盛科技（603610.SH）、北大医药（000788.SZ）涨停。 脑再生公司股价飙升，市场普遍认为这源于其在脑机接口领域取得的里程碑式突破有关。 多家内媒都报道，脑再生飙升的原因是5月9日其宣布新一代神经调控芯片通过FDA临床试验审批，并与梅奥诊所合作开展帕金森病治疗研究。 但是，大家可能误会了。财华社并没有从官方渠道确认这一消息，更蹊跷的是，连脑再生也没有在证监会公告甚至其官网的新闻稿中发布这一消息，有关消息的真实性存疑。 脑再生是一家怎样的公司？ 建基于香港的脑再生科技，表示自己是一家早期医药科学公司，专注于中医药的研究、开发和商业化，用于治疗神经认知障碍和退化性疾病，尤其是注意力缺陷多动障碍（Attention Deficit Hyperactivity Disorder，ADHD）和自闭症谱系障碍（Autism Spectrum Disorder，ASD）。 其目标是成为全球领先的中医药（TCM）研发与商业化企业，专注于治疗神经认知障碍和退行性疾病——尤其是ADHD和ASD，这些领
脑再生狂飙背后的玄机
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
港股解码
·
06-17 16:55
利好来袭，港、A两市脑机接口概念集体狂欢！
6月17日，A股的脑机接口概念股集体大涨，其中，
$爱朋医疗(300753)$
涨20%，
$熵基科技(301330)$
涨超14%，
$南京熊猫(600775)$
、
$创新医疗(002173)$
、三博脑科（301293.SZ）均大涨。 港股方面，南京熊猫电子股份（00553.HK）大涨超38%，
$微创脑科学(02172)$
大涨18.47%。 消息面，当地时间6月16日，在美上市的中概股公司脑再生科技（RGC.US）股价火箭般蹿升约283%，盘中多次熔断，收报60美元/股，创历史新高，公司总市值突破296亿美元，其年内累计涨幅高达数百倍。 股价的暴涨源于脑再生科技旗下新一代神经调控芯片通过FDA临床试验审批，该公司将与全球顶尖医疗机构梅奥诊所合作，开展帕金森病治疗研究。该神经调控芯片技术属于脑机接口领域的前沿方向，公司计划利用这一技术开展帕金森病治疗研究，直击全球约1000万患者市场。 脑再生科技的“核爆”无疑为脑机接口赛道注入一剂强心针，港、A两市相关概念股集体狂欢。 有分析认为，随着脑机接口技术的逐步成熟，有望解决帕金森、老年痴呆、失明、瘫痪、脑部损害等大部分神经退行性疾病，为恢复感觉和语言、运动功能等提供了希望，其应用前景以及未来市场空间被看好。麦肯锡预计，2030-2040年全球脑机接口医疗应用市场规模可达400亿至1450亿美元。 值得注意的是，
利好来袭，港、A两市脑机接口概念集体狂欢！
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
大黑鱼老师
·
06-04
$微创脑科学(02172)$
还有100%的空间
$微创脑科学(02172)$ 还有100%的空间
回复
评论
点赞
1
编组 21备份 2
分享
举报
港股解码
·
06-03
脑机接口板块热度升温！微创脑科学涨逾19.9%
6月3日，脑机接口概念股集体飙升。截至收盘，
$冠昊生物(300238)$
录得涨停板，
$翔宇医疗(688626)$
涨5.7%，创新医疗（002173.SZ）涨4.3%，三博脑科（301293.SZ）涨2.26%，爱朋医疗（300753.SZ）涨1.97%，中科信息（300678.SZ）、南京熊猫（600775.SH）均走强。 在港股市场，相关概念股同步冲高。截至发稿前，
$微创脑科学(02172)$
大涨19.96%，
$南京熊猫电子股份(00553)$
涨3.29%。 消息面，马斯克旗下脑机接口初创公司Neuralink宣布完成6.5亿美元E轮融资。该消息发布后，再一次引爆了脑机接口赛道。 所谓脑机接口，是一项通过采集和分析大脑的电信号，实现大脑与外部设备信息交换的技术。简单来说，它是大脑和机器之间的“翻译官”。如果该技术成熟，将有望解决老年痴呆、失明、瘫痪、脑部损害等大部分神经退行性疾病，为恢复感觉和语言、运动功能等提供希望。 近年来，脑机接口技术快速发展，除了国外利好消息频发外，国内脑机接口也进展不断。 近日，在上海召开的第20届亚洲神经肿瘤年会上，复旦大学附属华山医院院长毛颖教授透露，全球首个脑机接口临床队列研究已正式启动患者入组。该研究旨在系统验证植入式脑机接口在治疗中的有效性与安全性，为临床应用铺平道路。 5月8日，上海阶梯医疗展示了一段视频.视频中，脑机接口受试者可通过意念控制玩“马里奥赛车”游戏。这是国内首例侵入式脑机接口在注
脑机接口板块热度升温！微创脑科学涨逾19.9%
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Frankiewkc1128
·
02-12
$微創腦科學(02172)$
$微創腦科學(02172)$
# 晒晒更赚钱
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
智通财经APP
·
2024-10-17
微创脑科学（02172）：短期业绩增长靠集采，长期看国际化能力
近年来，微创系多家公司登录资本市场。然而从上半年业绩来看，在港股上市的微创系业绩增速普遍不错，但其他都处于亏损状态，仅微创脑科学(02172)一家盈利。 image.png 值得一提的是，微创脑科学从去年开始扭亏，并且自去年中报后业绩一直处于高增长状态，那么这一高增长是否可持续? 国产化率仍较低，集采下业绩成长有保障 提起集采，近几年医药行业的承压，多数归于集采的因素。不过神经介入领域则是受益于集采。 据智通财经APP了解，神经介入疗法主要指通过血管性介入疗法治疗神经血管疾病，是区别于药物和传统外科治疗的一种新型疗法。 而神经血管疾病包括血管狭窄、血栓形成、阻塞或动脉破裂等，其中脑卒中是最常见致命的神经血管疾病。神经血管疾病可主要分为三种疾病类型：出血性脑卒中(动脉渗血或破裂时发生)、急性缺血性脑卒中(大脑供血血管受阻)、脑动脉粥样硬化狭窄(血管内脂肪沉积形成斑块导致动脉狭窄并限制流向大脑的血流，斑块变大、变形或脱落等可能会导致急性缺血性脑卒中)。 由于人群基数大，老龄化持续加剧，中国的神经血管疾病发病率高，尤其是脑卒中是死亡的主要原因，相关治疗需求迫切且旺盛。根据器械之家，2019年中国脑卒中患者人数全球第一，总患者人数达1480万人，包括1190万缺血性脑卒中患者及290万出血性脑卒中患者，当年新发患者人数超过300万人。此外，颅内动脉狭窄、心房颤动、颅内动脉瘤均可能进展为脑卒中，相关患者人数庞大，2019年达到1.25亿人。 神经介入是疏通与修复脑血管通路的微创手术。传统治疗方式存在复发率高、创伤大、时间要求严格等弊端，因此神经介入手术日益普及，根据灼识咨询预测，中国神经介入手术数量有望从2020年的16.1万台手术增加至2026年的74.1 万台，CAGR达到28.9%。 手术量的提升，推动行业快速扩容，据沙利文数据显示，中国的神经介入市场规模由2015年26亿人民
微创脑科学（02172）：短期业绩增长靠集采，长期看国际化能力
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
kylines
·
2024-10-04
$微创脑科学(02172)$
太惨了，还回购都跌这么多
$微创脑科学(02172)$ 太惨了，还回购都跌这么多
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
kylines
·
2024-10-03
$微创脑科学(02172)$
涨幅最小，跌幅最大，真的垃圾
$微创脑科学(02172)$ 涨幅最小，跌幅最大，真的垃圾
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
kylines
·
2024-10-02
$微创脑科学(02172)$
能不能赶上你兄弟单位
$微创脑科学(02172)$ 能不能赶上你兄弟单位
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
kylines
·
2024-10-02
$微创脑科学(02172)$
为什么没人发现这个股票呢，很好啊
$微创脑科学(02172)$ 为什么没人发现这个股票呢，很好啊
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
kylines
·
2024-10-02
$微创脑科学(02172)$
脑科学怎么这么弱。。。🙁
$微创脑科学(02172)$ 脑科学怎么这么弱。。。🙁
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
港股解码
·
2024-09-13
医疗器械迎政策暖风，“微创系”强势反弹！
9月13日，港股的“微创系”走势活跃，
$微创机器人-B(02252)$
大涨14.24%，报7.38港元/股，市值71.7亿港元，
$微创医疗(00853)$
涨11.09%，报5.11港元/股，市值达93.77亿港元，
$微创脑科学(02172)$
涨超2%，报7.73港元/股，市值为45.19亿港元。 不过，心脉医疗（688016.SH）、心通医疗（02160.HK）、微电生理（688351.SH）均出现不同程度下跌。整体来看，“微创系”表现可圈可点。 消息面上，国家药品监督管理局局长李利今日在新闻发布会上介绍，我国医药创新活力持续增强，创新产品上市步伐不断加快；积极支持创新药械进医院、进医保；促进全球药物在中国同步研发、同步申报、同步审评、同步上市。国家药品监督管理局副局长雷平则表示，国家药监局全力促进医疗器械研发创新，推动科研成果尽快转化为创新产品。 有机构表示，当前市场对于医疗合规要求提升，在人口老龄化的大背景下，医疗器械行业的需求具备较强的韧性，国产替代仍在加速，集采的影响也在出清。长期来看，医疗器械板块的投资机会逐渐显现，“微创系”作为其中的佼佼者值得关注。 业绩方面，2024年上半年，微创医疗实现营收5.59亿美元，同比增长17.0%（剔除汇率影响），实现归母净亏损0.97亿美元，同比收窄40.5%。公司表示，旗下产品市场份额进一步提升，新产品贡献收入增量，同时公司坚持以改善盈利能力为导向，严格控制及降低研发和管理费用，从而实现大幅减亏。 此外，2024年上半年，微创机器人实现营收0.99亿元（人民币），同比大幅增
医疗器械迎政策暖风，“微创系”强势反弹！
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
公司概况
公司名称
微创脑科学
所属市场
SEHK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.medneurotech.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
微创脑科学有限公司是一家主要从事神经介入医疗器械研发和生产的投资控股公司。该公司的产品组合涵盖脑血管疾病的三大领域，即出血性脑卒中、动脉粥样硬化狭窄及急性缺血性脑卒中。该公司为患者和医生提供脑血管疾病一体化解决方案，包括术式和产品宣教、治疗方案建议、手术及器械使用培训、临床支持及术后跟踪随访等。该公司的主要产品包括Tubridge密网支架、Fastrack微导管系统、WILLIS颅内覆膜支架等。
06-02
股份购回
与截至二零二四年十二月三十一日止年度末期股息有关的以股代息；建议重选董事；建议选举独立非执行董事；建议续聘核数师；建议授出购回股份及发行股份的一般授权及股东周年大会通告
与截至二零二四年十二月三十一日止年度末期股息有关的以股代息；建议重选董事；建议选举独立非执行董事；建议续聘核数师；建议授出购回股份及发行股份的一般授权及股东周年大会通告
05-30
须予披露的交易
有关认购理财产品的须予披露交易
有关认购理财产品的须予披露交易
04-25
年度报告
2024年度报告
2024年度报告
03-26
股息分派
截至2024年12月31日止年度的末期股息
截至2024年12月31日止年度的末期股息
03-26
年度报告
截至2024年12月31日止年度之年度业绩公告
截至2024年12月31日止年度之年度业绩公告
01-12
业绩预告
正面盈利预告
正面盈利预告
2024-12-20
须予披露的交易
补充公告 - 成立投资基金
补充公告 - 成立投资基金
2024-12-16
须予披露的交易
须予披露交易 - 成立投资基金
须予披露交易 - 成立投资基金
2024-09-27
半年度报告
2024中期报告
2024中期报告
2024-08-28
股息分派
截至2024年6月30日止六个月的中期股息
截至2024年6月30日止六个月的中期股息
2024-08-28
半年度报告
截至2024年6月30日止六个月之未经审核中期业绩公告
截至2024年6月30日止六个月之未经审核中期业绩公告
2024-07-31
股息分派
截至2023年12月31日止年度的末期股息
截至2023年12月31日止年度的末期股息
2024-07-23
业绩预告
正面盈利预告
正面盈利预告
2024-07-02
业绩预告
2024年中期业绩预告
2024年中期业绩预告
2024-06-03
股份购回
与截至二零二三年十二月三十一日止年度末期股息有关的以股代息；建议选举及重选董事；建议续聘核数师；建议授出购回股份及发行股份的一般授权；建议更改公司名称；建议采纳新公司章程大纲细则及股东周年大会通告
与截至二零二三年十二月三十一日止年度末期股息有关的以股代息；建议选举及重选董事；建议续聘核数师；建议授出购回股份及发行股份的一般授权；建议更改公司名称；建议采纳新公司章程大纲细则及股东周年大会通告
分时
5日
日
周
月
数据加载中...
最高
14.660
今开
13.720
量比
1.10
最低
13.560
昨收
14.020
换手率
2.46%
热议股票
{"pagemeta":{"title":"微创脑科学(02172)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供微创脑科学(02172)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"微创脑科学,02172,微创脑科学股票,微创脑科学股票老虎,微创脑科学股票老虎国际,微创脑科学行情,微创脑科学股票行情,微创脑科学股价,微创脑科学股市,微创脑科学股票价格,微创脑科学股票交易,微创脑科学股票购买,微创脑科学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"微创脑科学(02172)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供微创脑科学(02172)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"02172","data":{"stockData":{"symbol":"02172","market":"HK","secType":"STK","nameCN":"微创脑科学","latestPrice":13.66,"timestamp":1750307495289,"preClose":14.02,"halted":0,"volume":14170000,"delay":0,"floatShares":576000000,"shares":576000000,"eps":0.4790001525841497,"marketStatus":"午间休市","change":-0.36,"latestTime":"06-19 12:31:35","open":13.72,"high":14.66,"low":13.56,"amount":199327640,"amplitude":0.078459,"askPrice":13.7,"askSize":1000,"bidPrice":13.66,"bidSize":14000,"shortable":3,"etf":0,"ttmEps":0.4790001525841497,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1750309200000},"marketStatusCode":3,"adr":0,"listingDate":1657814400000,"exchange":"SEHK","adjPreClose":14.02,"dividendRate":0.014259,"openAndCloseTimeList":[[1750296600000,1750305600000],[1750309200000,1750320000000]],"volumeRatio":1.098338,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.447300457381904","cardData":[{"tweetId":"447300457381904","author":{"authorId":"3514369206910047","idStr":"3514369206910047","name":"Sumire_9572","avatar":"https://static.tigerbbs.com/5e7fbf0b7a1ee37b79a360eb47696d4b","userType":1,"introduction":"","crmLevel":9,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":29,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/02172\">$微创脑科学(02172)$ </a> 开始直线拉升了，，，","plainDigest":"$微创脑科学(02172)$ 开始直线拉升了，，，","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1750225697392,"gmtModify":1750225698579,"symbols":["02172"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":118,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/447300457381904","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":36,"displayRows":2,"foldSize":0,"authorId":"3514369206910047"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.447291636965504","cardData":[{"tweetId":"447291636965504","author":{"authorId":"3514369206910047","idStr":"3514369206910047","name":"Sumire_9572","avatar":"https://static.tigerbbs.com/5e7fbf0b7a1ee37b79a360eb47696d4b","userType":1,"introduction":"","crmLevel":9,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":29,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/02172\">$微创脑科学(02172)$ </a> 马上拉升翻红，，，","plainDigest":"$微创脑科学(02172)$ 马上拉升翻红，，，","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1750223557986,"gmtModify":1750223559128,"symbols":["02172"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":111,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/447291636965504","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":34,"displayRows":2,"foldSize":0,"authorId":"3514369206910047"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.447292917097016","cardData":[{"tweetId":"447292917097016","author":{"authorId":"3514369206910047","idStr":"3514369206910047","name":"Sumire_9572","avatar":"https://static.tigerbbs.com/5e7fbf0b7a1ee37b79a360eb47696d4b","userType":1,"introduction":"","crmLevel":9,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":29,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/02172\">$微创脑科学(02172)$ </a> 本月有机会突破20+","plainDigest":"$微创脑科学(02172)$ 本月有机会突破20+","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1750223480386,"gmtModify":1750223481456,"symbols":["02172"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":113,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/447292917097016","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":36,"displayRows":2,"foldSize":0,"authorId":"3514369206910047"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.447300698841240","cardData":[{"tweetId":"447300698841240","author":{"authorId":"3514369206910047","idStr":"3514369206910047","name":"Sumire_9572","avatar":"https://static.tigerbbs.com/5e7fbf0b7a1ee37b79a360eb47696d4b","userType":1,"introduction":"","crmLevel":9,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":29,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/02172\">$微创脑科学(02172)$ </a> 感觉今天会翻红，，，近期牛股","plainDigest":"$微创脑科学(02172)$ 感觉今天会翻红，，，近期牛股","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1750223388205,"gmtModify":1750223389272,"symbols":["02172"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":10,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/447300698841240","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":44,"displayRows":2,"foldSize":0,"authorId":"3514369206910047"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.447290391433992","cardData":[{"tweetId":"447290391433992","author":{"authorId":"3514369206910047","idStr":"3514369206910047","name":"Sumire_9572","avatar":"https://static.tigerbbs.com/5e7fbf0b7a1ee37b79a360eb47696d4b","userType":1,"introduction":"","crmLevel":9,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":29,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/02172\">$微创脑科学(02172)$ </a> 继续低吸！！！","plainDigest":"$微创脑科学(02172)$ 继续低吸！！！","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1750223359619,"gmtModify":1750223360805,"symbols":["02172"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":21,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/447290391433992","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":30,"displayRows":2,"foldSize":0,"authorId":"3514369206910047"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.447176042819944","cardData":[{"tweetId":"447176042819944","author":{"authorId":"3514369206910047","idStr":"3514369206910047","name":"Sumire_9572","avatar":"https://static.tigerbbs.com/5e7fbf0b7a1ee37b79a360eb47696d4b","userType":1,"introduction":"","crmLevel":9,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":29,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/02172\">$微创脑科学(02172)$ </a> 开始直线拉升了！","plainDigest":"$微创脑科学(02172)$ 开始直线拉升了！","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1750216219380,"gmtModify":1750216220432,"symbols":["02172"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":58,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/447176042819944","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":34,"displayRows":2,"foldSize":0,"authorId":"3514369206910047"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.447257965310232","cardData":[{"tweetId":"447257965310232","author":{"authorId":"3514369206910047","idStr":"3514369206910047","name":"Sumire_9572","avatar":"https://static.tigerbbs.com/5e7fbf0b7a1ee37b79a360eb47696d4b","userType":1,"introduction":"","crmLevel":9,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":29,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/02172\">$微创脑科学(02172)$ </a> 低吸为主！！！16+","plainDigest":"$微创脑科学(02172)$ 低吸为主！！！16+","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1750214808018,"gmtModify":1750217603949,"symbols":["02172"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":52,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/447257965310232","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":33,"displayRows":2,"foldSize":0,"authorId":"3514369206910047"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.447114729746472","cardData":[{"tweetId":"447114729746472","author":{"authorId":"3514369206910047","idStr":"3514369206910047","name":"Sumire_9572","avatar":"https://static.tigerbbs.com/5e7fbf0b7a1ee37b79a360eb47696d4b","userType":1,"introduction":"","crmLevel":9,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":29,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/02172\">$微创脑科学(02172)$ </a> 低吸时刻！！！","plainDigest":"$微创脑科学(02172)$ 低吸时刻！！！","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1750211080977,"gmtModify":1750211434046,"symbols":["02172"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":18,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/447114729746472","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":30,"displayRows":2,"foldSize":0,"authorId":"3514369206910047"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.446967567958560","cardData":[{"tweetId":"446967567958560","author":{"authorId":"3478560277044805","idStr":"3478560277044805","name":"港股解码","avatar":"https://static.tigerbbs.com/0ddf8b49991624b6c7a49b9c67324a01","userType":2,"introduction":"港股解码，香港财华社原创王牌专栏，金融名家齐聚。看完记得订阅、评论、点赞哦。","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"累计发表精华帖>=3（或有料帖>=10），且30天内发表过至少一篇精华帖（或4篇有料帖）并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.19","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":1}],"fanSize":3518,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"脑再生狂飙背后的玄机","digest":"6月16日最让人瞠目结舌的股价表现，当属纳斯达克上市的 <a href=\"https://laohu8.com/S/RGC\">$脑再生科技(RGC)$</a> 。这家公司股价当天像坐火箭似的一路狂飙，接连触发多次熔断，最后收在60美元，涨幅高达283.12%。更夸张的是，从今年年初的0.13美元算起，这股价已经飙涨了460倍！ 受此带动，6月17日上午A股和港股脑机接口概念飙升， <a href=\"https://laohu8.com/S/00553\">$南京熊猫电子股份(00553)$</a> 一度涨超56%， <a href=\"https://laohu8.com/S/02172\">$微创脑科学(02172)$</a> 一度大涨45%，A股相关概念股南京熊猫（600775.SH）、麒盛科技（603610.SH）、北大医药（000788.SZ）涨停。 脑再生公司股价飙升，市场普遍认为这源于其在脑机接口领域取得的里程碑式突破有关。 多家内媒都报道，脑再生飙升的原因是5月9日其宣布新一代神经调控芯片通过FDA临床试验审批，并与梅奥诊所合作开展帕金森病治疗研究。 但是，大家可能误会了。财华社并没有从官方渠道确认这一消息，更蹊跷的是，连脑再生也没有在证监会公告甚至其官网的新闻稿中发布这一消息，有关消息的真实性存疑。 脑再生是一家怎样的公司？ 建基于香港的脑再生科技，表示自己是一家早期医药科学公司，专注于中医药的研究、开发和商业化，用于治疗神经认知障碍和退化性疾病，尤其是注意力缺陷多动障碍（Attention Deficit Hyperactivity Disorder，ADHD）和自闭症谱系障碍（Autism Spectrum Disorder，ASD）。 其目标是成为全球领先的中医药（TCM）研发与商业化企业，专注于治疗神经认知障碍和退行性疾病——尤其是ADHD和ASD，这些领","plainDigest":"6月16日最让人瞠目结舌的股价表现，当属纳斯达克上市的 $脑再生科技(RGC)$ 。这家公司股价当天像坐火箭似的一路狂飙，接连触发多次熔断，最后收在60美元，涨幅高达283.12%。更夸张的是，从今年年初的0.13美元算起，这股价已经飙涨了460倍！ 受此带动，6月17日上午A股和港股脑机接口概念飙升， $南京熊猫电子股份(00553)$ 一度涨超56%， $微创脑科学(02172)$ 一度大涨45%，A股相关概念股南京熊猫（600775.SH）、麒盛科技（603610.SH）、北大医药（000788.SZ）涨停。 脑再生公司股价飙升，市场普遍认为这源于其在脑机接口领域取得的里程碑式突破有关。 多家内媒都报道，脑再生飙升的原因是5月9日其宣布新一代神经调控芯片通过FDA临床试验审批，并与梅奥诊所合作开展帕金森病治疗研究。 但是，大家可能误会了。财华社并没有从官方渠道确认这一消息，更蹊跷的是，连脑再生也没有在证监会公告甚至其官网的新闻稿中发布这一消息，有关消息的真实性存疑。 脑再生是一家怎样的公司？ 建基于香港的脑再生科技，表示自己是一家早期医药科学公司，专注于中医药的研究、开发和商业化，用于治疗神经认知障碍和退化性疾病，尤其是注意力缺陷多动障碍（Attention Deficit Hyperactivity Disorder，ADHD）和自闭症谱系障碍（Autism Spectrum Disorder，ASD）。 其目标是成为全球领先的中医药（TCM）研发与商业化企业，专注于治疗神经认知障碍和退行性疾病——尤其是ADHD和ASD，这些领","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1750144250834,"gmtModify":1750145604812,"symbols":["00553","02172","RGC","600775"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":2,"images":[{"url":"https://static.tigerbbs.com/2b638826f72ce9eeee12f4043e6ba36a","width":"1370","height":"818"}],"repostCount":4,"viewCount":1776,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/446967567958560","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":3380,"displayRows":2,"foldSize":0,"authorId":"3478560277044805"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.446992854433880","cardData":[{"tweetId":"446992854433880","author":{"authorId":"3478560277044805","idStr":"3478560277044805","name":"港股解码","avatar":"https://static.tigerbbs.com/0ddf8b49991624b6c7a49b9c67324a01","userType":2,"introduction":"港股解码，香港财华社原创王牌专栏，金融名家齐聚。看完记得订阅、评论、点赞哦。","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"累计发表精华帖>=3（或有料帖>=10），且30天内发表过至少一篇精华帖（或4篇有料帖）并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.19","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":1}],"fanSize":3518,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"利好来袭，港、A两市脑机接口概念集体狂欢！","digest":"6月17日，A股的脑机接口概念股集体大涨，其中， <a href=\"https://laohu8.com/S/300753\">$爱朋医疗(300753)$</a> 涨20%， <a href=\"https://laohu8.com/S/301330\">$熵基科技(301330)$</a> 涨超14%， <a href=\"https://laohu8.com/S/600775\">$南京熊猫(600775)$</a> 、 <a href=\"https://laohu8.com/S/002173\">$创新医疗(002173)$</a> 、三博脑科（301293.SZ）均大涨。 港股方面，南京熊猫电子股份（00553.HK）大涨超38%， <a href=\"https://laohu8.com/S/02172\">$微创脑科学(02172)$</a> 大涨18.47%。 消息面，当地时间6月16日，在美上市的中概股公司脑再生科技（RGC.US）股价火箭般蹿升约283%，盘中多次熔断，收报60美元/股，创历史新高，公司总市值突破296亿美元，其年内累计涨幅高达数百倍。 股价的暴涨源于脑再生科技旗下新一代神经调控芯片通过FDA临床试验审批，该公司将与全球顶尖医疗机构梅奥诊所合作，开展帕金森病治疗研究。该神经调控芯片技术属于脑机接口领域的前沿方向，公司计划利用这一技术开展帕金森病治疗研究，直击全球约1000万患者市场。 脑再生科技的“核爆”无疑为脑机接口赛道注入一剂强心针，港、A两市相关概念股集体狂欢。 有分析认为，随着脑机接口技术的逐步成熟，有望解决帕金森、老年痴呆、失明、瘫痪、脑部损害等大部分神经退行性疾病，为恢复感觉和语言、运动功能等提供了希望，其应用前景以及未来市场空间被看好。麦肯锡预计，2030-2040年全球脑机接口医疗应用市场规模可达400亿至1450亿美元。 值得注意的是，","plainDigest":"6月17日，A股的脑机接口概念股集体大涨，其中， $爱朋医疗(300753)$ 涨20%， $熵基科技(301330)$ 涨超14%， $南京熊猫(600775)$ 、 $创新医疗(002173)$ 、三博脑科（301293.SZ）均大涨。 港股方面，南京熊猫电子股份（00553.HK）大涨超38%， $微创脑科学(02172)$ 大涨18.47%。 消息面，当地时间6月16日，在美上市的中概股公司脑再生科技（RGC.US）股价火箭般蹿升约283%，盘中多次熔断，收报60美元/股，创历史新高，公司总市值突破296亿美元，其年内累计涨幅高达数百倍。 股价的暴涨源于脑再生科技旗下新一代神经调控芯片通过FDA临床试验审批，该公司将与全球顶尖医疗机构梅奥诊所合作，开展帕金森病治疗研究。该神经调控芯片技术属于脑机接口领域的前沿方向，公司计划利用这一技术开展帕金森病治疗研究，直击全球约1000万患者市场。 脑再生科技的“核爆”无疑为脑机接口赛道注入一剂强心针，港、A两市相关概念股集体狂欢。 有分析认为，随着脑机接口技术的逐步成熟，有望解决帕金森、老年痴呆、失明、瘫痪、脑部损害等大部分神经退行性疾病，为恢复感觉和语言、运动功能等提供了希望，其应用前景以及未来市场空间被看好。麦肯锡预计，2030-2040年全球脑机接口医疗应用市场规模可达400亿至1450亿美元。 值得注意的是，","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1750150558938,"gmtModify":1750151758504,"symbols":["301330","02172","300753","600775","002173","00553"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":2,"images":[{"url":"https://static.tigerbbs.com/05f220906ebcc26bac8b57c8837bd5c7","width":"1269","height":"548"}],"repostCount":1,"viewCount":539,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/446992854433880","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":2467,"displayRows":2,"foldSize":0,"authorId":"3478560277044805"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.442399037051280","cardData":[{"tweetId":"442399037051280","author":{"authorId":"3468442827636541","idStr":"3468442827636541","name":"大黑鱼老师","avatar":"https://static.tigerbbs.com/ed107d4dd26711c36f92aadcb732166b","userType":1,"introduction":"","crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/02172\">$微创脑科学(02172)$</a> 还有100%的空间","plainDigest":"$微创脑科学(02172)$ 还有100%的空间","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1749029779542,"gmtModify":1749029780645,"symbols":["02172"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":288,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/442399037051280","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":33,"displayRows":2,"foldSize":0,"authorId":"3468442827636541"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.442071165214776","cardData":[{"tweetId":"442071165214776","author":{"authorId":"3478560277044805","idStr":"3478560277044805","name":"港股解码","avatar":"https://static.tigerbbs.com/0ddf8b49991624b6c7a49b9c67324a01","userType":2,"introduction":"港股解码，香港财华社原创王牌专栏，金融名家齐聚。看完记得订阅、评论、点赞哦。","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"累计发表精华帖>=3（或有料帖>=10），且30天内发表过至少一篇精华帖（或4篇有料帖）并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.19","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":1}],"fanSize":3518,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"脑机接口板块热度升温！微创脑科学涨逾19.9%","digest":"6月3日，脑机接口概念股集体飙升。截至收盘， <a href=\"https://laohu8.com/S/300238\">$冠昊生物(300238)$</a> 录得涨停板， <a href=\"https://laohu8.com/S/688626\">$翔宇医疗(688626)$</a> 涨5.7%，创新医疗（002173.SZ）涨4.3%，三博脑科（301293.SZ）涨2.26%，爱朋医疗（300753.SZ）涨1.97%，中科信息（300678.SZ）、南京熊猫（600775.SH）均走强。 在港股市场，相关概念股同步冲高。截至发稿前， <a href=\"https://laohu8.com/S/02172\">$微创脑科学(02172)$</a> 大涨19.96%， <a href=\"https://laohu8.com/S/00553\">$南京熊猫电子股份(00553)$</a> 涨3.29%。 消息面，马斯克旗下脑机接口初创公司Neuralink宣布完成6.5亿美元E轮融资。该消息发布后，再一次引爆了脑机接口赛道。 所谓脑机接口，是一项通过采集和分析大脑的电信号，实现大脑与外部设备信息交换的技术。简单来说，它是大脑和机器之间的“翻译官”。如果该技术成熟，将有望解决老年痴呆、失明、瘫痪、脑部损害等大部分神经退行性疾病，为恢复感觉和语言、运动功能等提供希望。 近年来，脑机接口技术快速发展，除了国外利好消息频发外，国内脑机接口也进展不断。 近日，在上海召开的第20届亚洲神经肿瘤年会上，复旦大学附属华山医院院长毛颖教授透露，全球首个脑机接口临床队列研究已正式启动患者入组。该研究旨在系统验证植入式脑机接口在治疗中的有效性与安全性，为临床应用铺平道路。 5月8日，上海阶梯医疗展示了一段视频.视频中，脑机接口受试者可通过意念控制玩“马里奥赛车”游戏。这是国内首例侵入式脑机接口在注","plainDigest":"6月3日，脑机接口概念股集体飙升。截至收盘， $冠昊生物(300238)$ 录得涨停板， $翔宇医疗(688626)$ 涨5.7%，创新医疗（002173.SZ）涨4.3%，三博脑科（301293.SZ）涨2.26%，爱朋医疗（300753.SZ）涨1.97%，中科信息（300678.SZ）、南京熊猫（600775.SH）均走强。 在港股市场，相关概念股同步冲高。截至发稿前， $微创脑科学(02172)$ 大涨19.96%， $南京熊猫电子股份(00553)$ 涨3.29%。 消息面，马斯克旗下脑机接口初创公司Neuralink宣布完成6.5亿美元E轮融资。该消息发布后，再一次引爆了脑机接口赛道。 所谓脑机接口，是一项通过采集和分析大脑的电信号，实现大脑与外部设备信息交换的技术。简单来说，它是大脑和机器之间的“翻译官”。如果该技术成熟，将有望解决老年痴呆、失明、瘫痪、脑部损害等大部分神经退行性疾病，为恢复感觉和语言、运动功能等提供希望。 近年来，脑机接口技术快速发展，除了国外利好消息频发外，国内脑机接口也进展不断。 近日，在上海召开的第20届亚洲神经肿瘤年会上，复旦大学附属华山医院院长毛颖教授透露，全球首个脑机接口临床队列研究已正式启动患者入组。该研究旨在系统验证植入式脑机接口在治疗中的有效性与安全性，为临床应用铺平道路。 5月8日，上海阶梯医疗展示了一段视频.视频中，脑机接口受试者可通过意念控制玩“马里奥赛车”游戏。这是国内首例侵入式脑机接口在注","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1748949824989,"gmtModify":1748956682792,"symbols":["300238","00553","02172","688626","600775"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/e5fe27037f8bbc2eb59c6bb74874d83b","width":"866","height":"375"}],"repostCount":0,"viewCount":554,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/442071165214776","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":1862,"displayRows":2,"foldSize":0,"authorId":"3478560277044805"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.402648044826904","cardData":[{"tweetId":"402648044826904","author":{"authorId":"4144829232746582","idStr":"4144829232746582","name":"Frankiewkc1128","avatar":"https://community-static.tradeup.com/news/ff1d9e05c0318f47e431459422b422c2","userType":1,"introduction":"","crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://ttm.financial/S/02172\">$微創腦科學(02172)$</a> ","plainDigest":"$微創腦科學(02172)$","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1739330406453,"gmtModify":1739330411381,"symbols":["02172"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"themes":[{"themeId":"5bfad02ab61749c8bfe6573ac7bbe8a3","themeType":0,"name":"晒晒更赚钱"}],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://community-static.tradeup.com/news/7aa525fb92d9af29efbada00a48387c0","width":"1092","height":"1717"}],"repostCount":0,"viewCount":613,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/402648044826904","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":19,"displayRows":2,"foldSize":0,"authorId":"4144829232746582"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.360999756816488","cardData":[{"tweetId":"360999756816488","author":{"authorId":"3513736945495657","idStr":"3513736945495657","name":"智通财经APP","avatar":"https://static.tigerbbs.com/16db7768af5d7e4361472f092e918510","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2198,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"微创脑科学（02172）：短期业绩增长靠集采，长期看国际化能力","digest":"近年来，微创系多家公司登录资本市场。然而从上半年业绩来看，在港股上市的微创系业绩增速普遍不错，但其他都处于亏损状态，仅微创脑科学(02172)一家盈利。 image.png 值得一提的是，微创脑科学从去年开始扭亏，并且自去年中报后业绩一直处于高增长状态，那么这一高增长是否可持续? 国产化率仍较低，集采下业绩成长有保障 提起集采，近几年医药行业的承压，多数归于集采的因素。不过神经介入领域则是受益于集采。 据智通财经APP了解，神经介入疗法主要指通过血管性介入疗法治疗神经血管疾病，是区别于药物和传统外科治疗的一种新型疗法。 而神经血管疾病包括血管狭窄、血栓形成、阻塞或动脉破裂等，其中脑卒中是最常见致命的神经血管疾病。神经血管疾病可主要分为三种疾病类型：出血性脑卒中(动脉渗血或破裂时发生)、急性缺血性脑卒中(大脑供血血管受阻)、脑动脉粥样硬化狭窄(血管内脂肪沉积形成斑块导致动脉狭窄并限制流向大脑的血流，斑块变大、变形或脱落等可能会导致急性缺血性脑卒中)。 由于人群基数大，老龄化持续加剧，中国的神经血管疾病发病率高，尤其是脑卒中是死亡的主要原因，相关治疗需求迫切且旺盛。根据器械之家，2019年中国脑卒中患者人数全球第一，总患者人数达1480万人，包括1190万缺血性脑卒中患者及290万出血性脑卒中患者，当年新发患者人数超过300万人。此外，颅内动脉狭窄、心房颤动、颅内动脉瘤均可能进展为脑卒中，相关患者人数庞大，2019年达到1.25亿人。 神经介入是疏通与修复脑血管通路的微创手术。传统治疗方式存在复发率高、创伤大、时间要求严格等弊端，因此神经介入手术日益普及，根据灼识咨询预测，中国神经介入手术数量有望从2020年的16.1万台手术增加至2026年的74.1 万台，CAGR达到28.9%。 手术量的提升，推动行业快速扩容，据沙利文数据显示，中国的神经介入市场规模由2015年26亿人民","plainDigest":"近年来，微创系多家公司登录资本市场。然而从上半年业绩来看，在港股上市的微创系业绩增速普遍不错，但其他都处于亏损状态，仅微创脑科学(02172)一家盈利。 image.png 值得一提的是，微创脑科学从去年开始扭亏，并且自去年中报后业绩一直处于高增长状态，那么这一高增长是否可持续? 国产化率仍较低，集采下业绩成长有保障 提起集采，近几年医药行业的承压，多数归于集采的因素。不过神经介入领域则是受益于集采。 据智通财经APP了解，神经介入疗法主要指通过血管性介入疗法治疗神经血管疾病，是区别于药物和传统外科治疗的一种新型疗法。 而神经血管疾病包括血管狭窄、血栓形成、阻塞或动脉破裂等，其中脑卒中是最常见致命的神经血管疾病。神经血管疾病可主要分为三种疾病类型：出血性脑卒中(动脉渗血或破裂时发生)、急性缺血性脑卒中(大脑供血血管受阻)、脑动脉粥样硬化狭窄(血管内脂肪沉积形成斑块导致动脉狭窄并限制流向大脑的血流，斑块变大、变形或脱落等可能会导致急性缺血性脑卒中)。 由于人群基数大，老龄化持续加剧，中国的神经血管疾病发病率高，尤其是脑卒中是死亡的主要原因，相关治疗需求迫切且旺盛。根据器械之家，2019年中国脑卒中患者人数全球第一，总患者人数达1480万人，包括1190万缺血性脑卒中患者及290万出血性脑卒中患者，当年新发患者人数超过300万人。此外，颅内动脉狭窄、心房颤动、颅内动脉瘤均可能进展为脑卒中，相关患者人数庞大，2019年达到1.25亿人。 神经介入是疏通与修复脑血管通路的微创手术。传统治疗方式存在复发率高、创伤大、时间要求严格等弊端，因此神经介入手术日益普及，根据灼识咨询预测，中国神经介入手术数量有望从2020年的16.1万台手术增加至2026年的74.1 万台，CAGR达到28.9%。 手术量的提升，推动行业快速扩容，据沙利文数据显示，中国的神经介入市场规模由2015年26亿人民","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1729162599283,"gmtModify":1729171854306,"symbols":["02172"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":5,"images":[{"url":"https://static.tigerbbs.com/0e2449da16e8b9003428053e3aa56023","width":"554","height":"228"},{"url":"https://static.tigerbbs.com/bbf98b9a1fe4c7595eaa28d1ecdbfc28","width":"554","height":"263"},{"url":"https://static.tigerbbs.com/2a49d9ae8774758e82ea091a246c8a3c","width":"554","height":"156"}],"repostCount":0,"viewCount":2501,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/360999756816488","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":6382,"displayRows":2,"foldSize":0,"authorId":"3513736945495657"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.356329981681912","cardData":[{"tweetId":"356329981681912","author":{"authorId":"3582712080709432","idStr":"3582712080709432","name":"kylines","avatar":"https://static.tigerbbs.com/50a893bbf1f94166db101b33baac3fcb","userType":1,"introduction":"","crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":7,"starInvestorFlag":true,"fullDisclosureFlag":false,"starInvestorFollowerNum":4,"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"userFollowInvestorFlag":false,"ror":28.61,"showRor":true,"winRationPercentage":51.219512,"dataLabelList":[],"tradeVolumeEst":0},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"userFollowInvestorFlag":false,"digest":"<a href=\"https://laohu8.com/S/02172\">$微创脑科学(02172)$</a> 太惨了，还回购都跌这么多","plainDigest":"$微创脑科学(02172)$ 太惨了，还回购都跌这么多","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1728004092153,"gmtModify":1728004093682,"symbols":["02172"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1400,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/356329981681912","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":42,"displayRows":2,"foldSize":0,"authorId":"3582712080709432"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.356024892219784","cardData":[{"tweetId":"356024892219784","author":{"authorId":"3582712080709432","idStr":"3582712080709432","name":"kylines","avatar":"https://static.tigerbbs.com/50a893bbf1f94166db101b33baac3fcb","userType":1,"introduction":"","crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":7,"starInvestorFlag":true,"fullDisclosureFlag":false,"starInvestorFollowerNum":4,"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"userFollowInvestorFlag":false,"ror":28.61,"showRor":true,"winRationPercentage":51.219512,"dataLabelList":[],"tradeVolumeEst":0},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"userFollowInvestorFlag":false,"digest":"<a href=\"https://laohu8.com/S/02172\">$微创脑科学(02172)$</a> 涨幅最小，跌幅最大，真的垃圾","plainDigest":"$微创脑科学(02172)$ 涨幅最小，跌幅最大，真的垃圾","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1727922315093,"gmtModify":1727924717349,"symbols":["02172"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1305,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/356024892219784","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":45,"displayRows":2,"foldSize":0,"authorId":"3582712080709432"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.355718299574496","cardData":[{"tweetId":"355718299574496","author":{"authorId":"3582712080709432","idStr":"3582712080709432","name":"kylines","avatar":"https://static.tigerbbs.com/50a893bbf1f94166db101b33baac3fcb","userType":1,"introduction":"","crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":7,"starInvestorFlag":true,"fullDisclosureFlag":false,"starInvestorFollowerNum":4,"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"userFollowInvestorFlag":false,"ror":28.61,"showRor":true,"winRationPercentage":51.219512,"dataLabelList":[],"tradeVolumeEst":0},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"userFollowInvestorFlag":false,"digest":"<a href=\"https://laohu8.com/S/02172\">$微创脑科学(02172)$</a> 能不能赶上你兄弟单位","plainDigest":"$微创脑科学(02172)$ 能不能赶上你兄弟单位","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1727847261729,"gmtModify":1727847263325,"symbols":["02172"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1299,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/355718299574496","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":39,"displayRows":2,"foldSize":0,"authorId":"3582712080709432"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.355688182935832","cardData":[{"tweetId":"355688182935832","author":{"authorId":"3582712080709432","idStr":"3582712080709432","name":"kylines","avatar":"https://static.tigerbbs.com/50a893bbf1f94166db101b33baac3fcb","userType":1,"introduction":"","crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":7,"starInvestorFlag":true,"fullDisclosureFlag":false,"starInvestorFollowerNum":4,"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"userFollowInvestorFlag":false,"ror":28.61,"showRor":true,"winRationPercentage":51.219512,"dataLabelList":[],"tradeVolumeEst":0},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"userFollowInvestorFlag":false,"digest":"<a href=\"https://laohu8.com/S/02172\">$微创脑科学(02172)$ </a> 为什么没人发现这个股票呢，很好啊","plainDigest":"$微创脑科学(02172)$ 为什么没人发现这个股票呢，很好啊","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1727839910698,"gmtModify":1727839912379,"symbols":["02172"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1062,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/355688182935832","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":50,"displayRows":2,"foldSize":0,"authorId":"3582712080709432"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.355636275638544","cardData":[{"tweetId":"355636275638544","author":{"authorId":"3582712080709432","idStr":"3582712080709432","name":"kylines","avatar":"https://static.tigerbbs.com/50a893bbf1f94166db101b33baac3fcb","userType":1,"introduction":"","crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":7,"starInvestorFlag":true,"fullDisclosureFlag":false,"starInvestorFollowerNum":4,"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"userFollowInvestorFlag":false,"ror":28.61,"showRor":true,"winRationPercentage":51.219512,"dataLabelList":[],"tradeVolumeEst":0},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"userFollowInvestorFlag":false,"digest":"<a href=\"https://laohu8.com/S/02172\">$微创脑科学(02172)$ </a> 脑科学怎么这么弱。。。🙁","plainDigest":"$微创脑科学(02172)$ 脑科学怎么这么弱。。。🙁","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1727834819710,"gmtModify":1727834821140,"symbols":["02172"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1079,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/355636275638544","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":40,"displayRows":2,"foldSize":0,"authorId":"3582712080709432"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.348969710366992","cardData":[{"tweetId":"348969710366992","author":{"authorId":"3478560277044805","idStr":"3478560277044805","name":"港股解码","avatar":"https://static.tigerbbs.com/0ddf8b49991624b6c7a49b9c67324a01","userType":2,"introduction":"港股解码，香港财华社原创王牌专栏，金融名家齐聚。看完记得订阅、评论、点赞哦。","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"累计发表精华帖>=3（或有料帖>=10），且30天内发表过至少一篇精华帖（或4篇有料帖）并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.19","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":1}],"fanSize":3518,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"医疗器械迎政策暖风，“微创系”强势反弹！","digest":"9月13日，港股的“微创系”走势活跃， <a href=\"https://laohu8.com/S/02252\">$微创机器人-B(02252)$</a> 大涨14.24%，报7.38港元/股，市值71.7亿港元， <a href=\"https://laohu8.com/S/00853\">$微创医疗(00853)$</a> 涨11.09%，报5.11港元/股，市值达93.77亿港元， <a href=\"https://laohu8.com/S/02172\">$微创脑科学(02172)$</a> 涨超2%，报7.73港元/股，市值为45.19亿港元。 不过，心脉医疗（688016.SH）、心通医疗（02160.HK）、微电生理（688351.SH）均出现不同程度下跌。整体来看，“微创系”表现可圈可点。 消息面上，国家药品监督管理局局长李利今日在新闻发布会上介绍，我国医药创新活力持续增强，创新产品上市步伐不断加快；积极支持创新药械进医院、进医保；促进全球药物在中国同步研发、同步申报、同步审评、同步上市。国家药品监督管理局副局长雷平则表示，国家药监局全力促进医疗器械研发创新，推动科研成果尽快转化为创新产品。 有机构表示，当前市场对于医疗合规要求提升，在人口老龄化的大背景下，医疗器械行业的需求具备较强的韧性，国产替代仍在加速，集采的影响也在出清。长期来看，医疗器械板块的投资机会逐渐显现，“微创系”作为其中的佼佼者值得关注。 业绩方面，2024年上半年，微创医疗实现营收5.59亿美元，同比增长17.0%（剔除汇率影响），实现归母净亏损0.97亿美元，同比收窄40.5%。公司表示，旗下产品市场份额进一步提升，新产品贡献收入增量，同时公司坚持以改善盈利能力为导向，严格控制及降低研发和管理费用，从而实现大幅减亏。 此外，2024年上半年，微创机器人实现营收0.99亿元（人民币），同比大幅增","plainDigest":"9月13日，港股的“微创系”走势活跃， $微创机器人-B(02252)$ 大涨14.24%，报7.38港元/股，市值71.7亿港元， $微创医疗(00853)$ 涨11.09%，报5.11港元/股，市值达93.77亿港元， $微创脑科学(02172)$ 涨超2%，报7.73港元/股，市值为45.19亿港元。 不过，心脉医疗（688016.SH）、心通医疗（02160.HK）、微电生理（688351.SH）均出现不同程度下跌。整体来看，“微创系”表现可圈可点。 消息面上，国家药品监督管理局局长李利今日在新闻发布会上介绍，我国医药创新活力持续增强，创新产品上市步伐不断加快；积极支持创新药械进医院、进医保；促进全球药物在中国同步研发、同步申报、同步审评、同步上市。国家药品监督管理局副局长雷平则表示，国家药监局全力促进医疗器械研发创新，推动科研成果尽快转化为创新产品。 有机构表示，当前市场对于医疗合规要求提升，在人口老龄化的大背景下，医疗器械行业的需求具备较强的韧性，国产替代仍在加速，集采的影响也在出清。长期来看，医疗器械板块的投资机会逐渐显现，“微创系”作为其中的佼佼者值得关注。 业绩方面，2024年上半年，微创医疗实现营收5.59亿美元，同比增长17.0%（剔除汇率影响），实现归母净亏损0.97亿美元，同比收窄40.5%。公司表示，旗下产品市场份额进一步提升，新产品贡献收入增量，同时公司坚持以改善盈利能力为导向，严格控制及降低研发和管理费用，从而实现大幅减亏。 此外，2024年上半年，微创机器人实现营收0.99亿元（人民币），同比大幅增","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1726227426323,"gmtModify":1726228901145,"symbols":["02172","00853","02252"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":2,"images":[{"url":"https://static.tigerbbs.com/5cf0f02467e151bf2bda76c3c13b9393","width":"691","height":"451"}],"repostCount":0,"viewCount":1937,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/348969710366992","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":2087,"displayRows":2,"foldSize":0,"authorId":"3478560277044805"}],"position":0}],"size":20,"extra":{"requestId":"afabae2ad7c84a31a5b483b88ad18bc1","feedVerCode":"2"}},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":true,"hasAttachments":false,"id":"19719057","market":"hk","labels":[],"media":"港交所","original_id":"N.HK7WxnhufWmp","pdf_url":"https://static.tigerbbs.com/1dbafcfc84fb4fe9a98040996ecc8cc1","pub_time":1748853300000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"与截至二零二四年十二月三十一日止年度末期股息有关的以股代息；建议重选董事；建议选举独立非执行董事；建议续聘核数师；建议授出购回股份及发行股份的一般授权及股东周年大会通告","symbol":"02172","title":"与截至二零二四年十二月三十一日止年度末期股息有关的以股代息；建议重选董事；建议选举独立非执行董事；建议续聘核数师；建议授出购回股份及发行股份的一般授权及股东周年大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0602/2025060201649_c.pdf","us_notice_code":"通函 - [一般性授权 / 在股东批准的情况下重选或委任董事 / 回购股份的说明函件 / 其他]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2025-06-02 16:35","pubTimestamp":1748853300,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19714908","market":"hk","labels":[],"media":"港交所","original_id":"N.HK91cRET8ceM","pdf_url":"https://static.tigerbbs.com/f7b7906533c04a018d379e5201da0cec","pub_time":1748613780000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"有关认购理财产品的须予披露交易","symbol":"02172","title":"有关认购理财产品的须予披露交易","titleType":"须予披露的交易","type":"hkTrade","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0530/2025053002292_c.pdf","us_notice_code":"公告及通告 - [须予披露的交易]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易相关","type_name_en":"Transaction Related","titleTypeEn":"","event_type":"important_notice","event_name":"须予披露的交易","pubTime":"2025-05-30 22:03","pubTimestamp":1748613780,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19495159","market":"hk","labels":[],"media":"港交所","original_id":"N.HKCdKzF1XGht","pdf_url":"https://static.tigerbbs.com/cc558c0f737a4b658deafb1fc11b8ea7","pub_time":1745573220000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2024年度报告","symbol":"02172","title":"2024年度报告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0425/2025042501794_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报 / 环境、社会及管治资料/报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2025-04-25 17:27","pubTimestamp":1745573220,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19288120","market":"hk","labels":[],"media":"港交所","original_id":"N.HKGLDZRBi93F","pdf_url":"https://static.tigerbbs.com/e9478aedb0ad48b3ac0a67d5b72a2fec","pub_time":1742996760000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2024年12月31日止年度的末期股息","symbol":"02172","title":"截至2024年12月31日止年度的末期股息","titleType":"股息分派","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0326/2025032601877_c.pdf","us_notice_code":"公告及通告 - [股息或分派（公告表格）]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Dividend","event_type":"important_notice","event_name":"股息分派","pubTime":"2025-03-26 21:46","pubTimestamp":1742996760,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19287404","market":"hk","labels":[],"media":"港交所","original_id":"N.HK4ukbyHoMQc","pdf_url":"https://static.tigerbbs.com/87941f87a50248ff8a9d50caf391ef3d","pub_time":1742993160000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2024年12月31日止年度之年度业绩公告","symbol":"02172","title":"截至2024年12月31日止年度之年度业绩公告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0326/2025032601485_c.pdf","us_notice_code":"公告及通告 - [末期业绩 / 股息或分派 / 暂停办理过户登记手续或更改暂停办理过户日期]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2025-03-26 20:46","pubTimestamp":1742993160,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19035768","market":"hk","labels":[],"media":"港交所","original_id":"N.HKJ8G9pkrdir","pdf_url":"https://static.tigerbbs.com/8d3ced6c5e0f4be3af4c68873abdac66","pub_time":1736683080000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"正面盈利预告","symbol":"02172","title":"正面盈利预告","titleType":"业绩预告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0112/2025011200162_c.pdf","us_notice_code":"公告及通告 - [盈利警告 / 内幕消息]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Earnings Estimation","event_type":"important_notice","event_name":"业绩预告","pubTime":"2025-01-12 19:58","pubTimestamp":1736683080,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18967050","market":"hk","labels":[],"media":"港交所","original_id":"N.HKGepDuybKYa","pdf_url":"https://static.tigerbbs.com/070897a625704f7d8582641f209c81c2","pub_time":1734703200000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"补充公告 - 成立投资基金","symbol":"02172","title":"补充公告 - 成立投资基金","titleType":"须予披露的交易","type":"hkTrade","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/1220/2024122001793_c.pdf","us_notice_code":"公告及通告 - [须予披露的交易]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易相关","type_name_en":"Transaction Related","titleTypeEn":"","event_type":"important_notice","event_name":"须予披露的交易","pubTime":"2024-12-20 22:00","pubTimestamp":1734703200,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18948371","market":"hk","labels":[],"media":"港交所","original_id":"N.HKGpF3AQiKmG","pdf_url":"https://static.tigerbbs.com/f5bca561853f4929a05da46f1b7a6c0a","pub_time":1734357600000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"须予披露交易 - 成立投资基金","symbol":"02172","title":"须予披露交易 - 成立投资基金","titleType":"须予披露的交易","type":"hkTrade","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/1216/2024121601141_c.pdf","us_notice_code":"公告及通告 - [须予披露的交易]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易相关","type_name_en":"Transaction Related","titleTypeEn":"","event_type":"important_notice","event_name":"须予披露的交易","pubTime":"2024-12-16 22:00","pubTimestamp":1734357600,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18653453","market":"hk","labels":[],"media":"港交所","original_id":"N.HKHLBbd1QBkK","pdf_url":"https://static.tigerbbs.com/ded4b96835364353ac7783ee854f0635","pub_time":1727425860000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2024中期报告","symbol":"02172","title":"2024中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0927/2024092700592_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2024-09-27 16:31","pubTimestamp":1727425860,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18541644","market":"hk","labels":[],"media":"港交所","original_id":"N.HK9ZDv2v5Ssc","pdf_url":"https://static.tigerbbs.com/006aa9b5c9eb4ed7973e1f630b662699","pub_time":1724856600000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2024年6月30日止六个月的中期股息","symbol":"02172","title":"截至2024年6月30日止六个月的中期股息","titleType":"股息分派","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0828/2024082802264_c.pdf","us_notice_code":"公告及通告 - [股息或分派（公告表格）]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Dividend","event_type":"important_notice","event_name":"股息分派","pubTime":"2024-08-28 22:50","pubTimestamp":1724856600,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18541638","market":"hk","labels":[],"media":"港交所","original_id":"N.HKB67ZnBcsic","pdf_url":"https://static.tigerbbs.com/1348a4b6a3f24ac9a256ec4d8a39eaee","pub_time":1724856480000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2024年6月30日止六个月之未经审核中期业绩公告","symbol":"02172","title":"截至2024年6月30日止六个月之未经审核中期业绩公告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0828/2024082802258_c.pdf","us_notice_code":"公告及通告 - [中期业绩 / 股息或分派 / 暂停办理过户登记手续或更改暂停办理过户日期]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2024-08-28 22:48","pubTimestamp":1724856480,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18419692","market":"hk","labels":[],"media":"港交所","original_id":"N.HKCTAgUa6HtT","pdf_url":"https://static.tigerbbs.com/584220604d74433584a0265358d144d6","pub_time":1722414900000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2023年12月31日止年度的末期股息","symbol":"02172","title":"截至2023年12月31日止年度的末期股息","titleType":"股息分派","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0731/2024073100468_c.pdf","us_notice_code":"公告及通告 - [股息或分派（公告表格）]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Dividend","event_type":"important_notice","event_name":"股息分派","pubTime":"2024-07-31 16:35","pubTimestamp":1722414900,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18395190","market":"hk","labels":[],"media":"港交所","original_id":"N.HK2vV2jrynWT","pdf_url":"https://static.tigerbbs.com/998ac795da904cfca7a1334cfd7fb879","pub_time":1721739780000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"正面盈利预告","symbol":"02172","title":"正面盈利预告","titleType":"业绩预告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0723/2024072300850_c.pdf","us_notice_code":"公告及通告 - [盈利警告 / 内幕消息]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Earnings Estimation","event_type":"important_notice","event_name":"业绩预告","pubTime":"2024-07-23 21:03","pubTimestamp":1721739780,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18333515","market":"hk","labels":[],"media":"港交所","original_id":"N.HK7AgePCSsCy","pdf_url":"https://static.tigerbbs.com/60af439a7c084243b455b04d52a04d21","pub_time":1719913200000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2024年中期业绩预告","symbol":"02172","title":"2024年中期业绩预告","titleType":"业绩预告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0702/2024070202582_c.pdf","us_notice_code":"公告及通告 - [盈利警告 / 内幕消息]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Earnings Estimation","event_type":"important_notice","event_name":"业绩预告","pubTime":"2024-07-02 17:40","pubTimestamp":1719913200,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18222940","market":"hk","labels":[],"media":"港交所","original_id":"N.HKEcDvEKUJVR","pdf_url":"https://static.tigerbbs.com/18a4945d4c084d20b822295d11fd0184","pub_time":1717404840000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"与截至二零二三年十二月三十一日止年度末期股息有关的以股代息；建议选举及重选董事；建议续聘核数师；建议授出购回股份及发行股份的一般授权；建议更改公司名称；建议采纳新公司章程大纲细则及股东周年大会通告","symbol":"02172","title":"与截至二零二三年十二月三十一日止年度末期股息有关的以股代息；建议选举及重选董事；建议续聘核数师；建议授出购回股份及发行股份的一般授权；建议更改公司名称；建议采纳新公司章程大纲细则及股东周年大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0603/2024060302237_c.pdf","us_notice_code":"通函 - [一般性授权 / 在股东批准的情况下重选或委任董事 / 回购股份的说明函件 / 修订宪章文件 / 其他]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2024-06-03 16:54","pubTimestamp":1717404840,"notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.medneurotech.com","stockEarnings":[{"period":"1week","weight":0.097},{"period":"1month","weight":0.3378},{"period":"3month","weight":0.067},{"period":"6month","weight":0.586},{"period":"1year","weight":1.0149},{"period":"ytd","weight":0.6283}],"compareEarnings":[{"period":"1week","weight":-0.0269},{"period":"1month","weight":0.0162},{"period":"3month","weight":-0.021},{"period":"6month","weight":0.2023},{"period":"1year","weight":0.3235},{"period":"ytd","weight":0.182}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"微创脑科学有限公司是一家主要从事神经介入医疗器械研发和生产的投资控股公司。该公司的产品组合涵盖脑血管疾病的三大领域，即出血性脑卒中、动脉粥样硬化狭窄及急性缺血性脑卒中。该公司为患者和医生提供脑血管疾病一体化解决方案，包括术式和产品宣教、治疗方案建议、手术及器械使用培训、临床支持及术后跟踪随访等。该公司的主要产品包括Tubridge密网支架、Fastrack微导管系统、WILLIS颅内覆膜支架等。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.12591},{"month":2,"riseRate":0.666667,"avgChangeRate":0.057452},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.071297},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.013204},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.047258},{"month":6,"riseRate":0.666667,"avgChangeRate":0.072416},{"month":7,"riseRate":0.5,"avgChangeRate":0.11057},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.034444},{"month":9,"riseRate":0.666667,"avgChangeRate":0.07813},{"month":10,"riseRate":1,"avgChangeRate":0.021811},{"month":11,"riseRate":0,"avgChangeRate":-0.086889},{"month":12,"riseRate":0.666667,"avgChangeRate":0.025459}],"exchange":"SEHK","name":"微创脑科学","nameEN":"MICROPORT NEURO"},"aProfile":null}}}